Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022
Cash & Equivalents	41.04	30.63	61.58	9.24	20.99	55.89
Short-Term Investments	160.65	114.11	165.34	-	22.76	-
Cash & Short-Term Investments	201.7	144.74	226.92	9.24	43.76	55.89
Cash Growth	15.82%	-36.22%	2356.33%	-78.89%	-21.71%	-12.44%
Accounts Receivable	0.01	0.01	0.12	1.17	1.36	1.61
Other Receivables	-	1.03	1.37	0.01	0	0.02
Receivables	0.01	1.04	1.48	1.18	7.47	1.63
Inventory	-	-	-	-	-	1.4
Prepaid Expenses	3.58	2.58	2.68	1.08	0.44	0.39
Other Current Assets	-	0.04	0.08	5.35	1.54	0.03
Total Current Assets	205.28	148.39	231.16	16.84	53.22	59.33
Property, Plant & Equipment	119.87	78.1	59.54	6.32	0.37	2.49
Long-Term Investments	-	0.12	0.13	0.13	0.15	-
Goodwill	-	-	-	24.06	-	-
Other Intangible Assets	40	40	50.01	50.35	0.03	0.11
Other Long-Term Assets	0.53	0.36	0.27	0.18	4.33	2.52
Total Assets	365.68	266.97	341.1	97.89	58.09	64.44

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022
Accounts Payable	31.42	20.31	9.84	6.41	1.54	0.97
Accrued Expenses	6.81	7.49	5.48	3.59	1.3	1.03
Current Portion of Long-Term Debt	0.06	0.06	0.05	0.05	-	-
Current Portion of Leases	1.12	0.62	0.96	0.05	-	0.27
Current Unearned Revenue	-	-	1.4	-	-	-
Other Current Liabilities	0.2	0.2	0.5	5.57	0.28	-
Total Current Liabilities	39.6	28.68	18.23	15.66	3.12	2.27
Long-Term Debt	1.53	1.57	1.63	1.68	-	-
Long-Term Leases	0.98	1.01	1.43	0.78	-	0.26
Long-Term Unearned Revenue	26.6	26.6	26.6	-	-	-
Long-Term Deferred Tax Liabilities	1.7	1.7	2.5	4.59	-	-
Other Long-Term Liabilities	0.6	0.39	0.06	-	0.33	0.64
Total Liabilities	71	59.94	50.43	22.71	3.45	3.16

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022
Common Stock	0.11	0.07	0.07	0.03	0.14	0.14
Additional Paid-In Capital	715.1	541.69	522.37	227.59	160.43	159.73
Retained Earnings	-420.26	-334.84	-231.72	-152.44	-105.93	-98.6
Comprehensive Income & Other	-0.28	0.11	-0.05	-	-	-
Shareholders' Equity	294.68	207.03	290.67	75.18	54.64	61.28
Total Liabilities & Equity	365.68	266.97	341.1	97.89	58.09	64.44

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022
Total Debt	3.68	3.25	4.06	2.55	-	0.52
Net Cash (Debt)	198.02	141.48	222.85	6.69	43.76	55.37
Net Cash Growth	15.92%	-36.51%	3232.64%	-84.72%	-20.97%	-12.19%
Net Cash Per Share	1.89	1.92	3.46	0.25	3.08	3.90
Filing Date Shares Outstanding	120.76	113.93	74.05	58.69	28	14.21
Total Common Shares Outstanding	114.16	74.34	70.67	28.18	14.21	14.2
Working Capital	165.68	119.71	212.93	1.17	50.1	57.06
Book Value Per Share	2.58	2.78	4.11	2.67	3.84	4.31
Tangible Book Value	254.68	167.03	240.66	0.76	54.62	61.17
Tangible Book Value Per Share	2.23	2.25	3.41	0.03	3.84	4.31
Land	0.92	0.92	0.92	1.28	0.37	0.37
Buildings	1.77	1.77	1.77	1.77	-	-
Machinery	17.33	15.46	11.42	2.68	0.02	4.44
Construction In Progress	103.62	60.79	42.6	-	-	-
Leasehold Improvements	3.94	3.86	3.57	0.18	-	4.14

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 9, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 15, 2026

Data Sources Report a data error